8-K: Tempest Therapeutics — Agreement and Officer Changes
Tempest Therapeutics filed an 8-K reporting a material agreement, officer changes, and Regulation FD disclosures.
Tempest Therapeutics filed an 8-K reporting a material agreement, officer changes, and Regulation FD disclosures.